Werewolf Therapeutics Inc (HOWL) SEC News Oct. 29, 2025, 23:21 UTC 1 1 comments GADICKE ANSBERT 🔴 sold 276.0K shares of Werewolf Therapeutics, Inc. (HOWL) at $1.72 Transaction Date: Oct 27, 2025 | Filing ID: 000373 Comment Full text
Neumora Therapeutics Inc. (NMRA) SEC News Oct. 29, 2025, 23:19 UTC 1 1 comments ARCH Venture Partners X, LLC 🟢 acquired 1.9M shares of Neumora Therapeutics, Inc. (NMRA) at $2.61 ($5.0M) Transaction Date: Oct 27, 2025 | Filing ID: 000679 Comment Full text
Neumora Therapeutics Inc. (NMRA) SEC News Oct. 29, 2025, 23:07 UTC 1 0 comments New Form SCHEDULE 13D/A - Neumora Therapeutics, Inc. Filed: 2025-10-29 AccNo: 0001012975-25-000675 Size: 36 KB Comment Full text
Galapagos N.V. (GLPGF) SEC News Oct. 29, 2025, 22:31 UTC 1 0 comments New Form SCHEDULE 13G - GALAPAGOS NV Filed: 2025-10-29 AccNo: 0001214659-25-015518 Size: 29 KB Comment Full text
COMPASS Pathways plc (CMPS) SEC News Oct. 29, 2025, 22:16 UTC 1 0 comments New Form SCHEDULE 13D/A - COMPASS Pathways plc Filed: 2025-10-29 AccNo: 0001140361-25-039738 Size: 8 KB Comment Full text
DaVita HealthCare Partners Inc (DVA) SEC News Oct. 29, 2025, 22:09 UTC 1 1 comments BERKSHIRE HATHAWAY INC 🔴 sold 401.5K shares of DAVITA INC. (DVA) at $135.36 ($54.3M) Transaction Date: Oct 27, 2025 | Filing ID: 256858 Comment Full text
X4 Pharmaceuticals Inc. (XFOR) SEC News Oct. 29, 2025, 22:05 UTC 1 0 comments New Form SCHEDULE 13D/A - X4 Pharmaceuticals, Inc Filed: 2025-10-29 AccNo: 0001072613-25-000747 Size: 92 KB Comment Full text
Cyclacel Pharmaceuticals Inc. (CYCCP) SEC News Oct. 29, 2025, 22:00 UTC 1 1 comments Yap Kim Choy 🔴 sold 120.2K shares of Bio Green Med Solution, Inc. (BGMS) at $2.12 Transaction Date: Oct 27, 2025 | Filing ID: 020109 Comment Full text
BridgeBio Pharma (BBIO) SEC News Oct. 29, 2025, 21:59 UTC 1 1 comments 📋 Frank McCormick (Director) plans to sell 198K shares of BridgeBio Pharma (at $66.58 each, total $13.2M) Filed: Oct 29, 2025 | ID: 047224 Comment Full text
Lyell Immunopharma (LYEL) SEC News Oct. 29, 2025, 21:42 UTC 1 1 comments Hill Stephen J. 🟢 acquired 75.0K shares (1 derivative) of Lyell Immunopharma, Inc. (LYEL) at $17.23 ($1.3M) Transaction Date: Oct 27, 2025 | Filing ID: 000005 Comment Full text